LU; Patrick Y.

Patent Applications and Registrations

Patent applications and USPTO patent grants for LU; Patrick Y..The latest application filed is for "co-delivery of tgf-b sirna and pdl1 sirna to treat cancer".

Company Profile

5.20.41

LU; Patrick Y. - Gaithersburg MD
LU; Patrick Y. - Potomac MD
Lu; Patrick Y. - Guangzhou CN
Lu; Patrick Y - Potomac MD
Lu; Patrick Y. - Rockville MD US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
CO-DELIVERY OF TGF-B siRNA AND PDL1 siRNA TO TREAT CANCER App 20220282258 - EVANS; David M. ; et al.	2022-09-08
siRNA/Nanoparticle Formulations for Treatment of Middle-East Respiratory Syndrome Coronaviral Infection App 20220145301 - LU; Patrick Y. ; et al.	2022-05-12
Targeted Delivery of Therapeutic Molecules App 20220054645 - LU; Xiaoyong ; et al.	2022-02-24
Composition and Method of mRNA Vaccines Against Novel Coronavirus Infection App 20220040292 - TANG; Shenggao ; et al.	2022-02-10
SILENCING TGF-BETA 1 and COX2 USING siRNAs DELIVERED in a POLYPEPTIDE NANOPARTICLE ALONE and in COMBINATION with IMMUNE CHECKPOINT INHIBITORS to TREAT CANCER App 20210324384 - EVANS; David M. ; et al.	2021-10-21
COMPOSITION AND METHODS OF RNAi PROPHYLACTICS AND THERAPEUTICS FOR TREATMENT OF SEVERE ACUTE RESPIRATORY INFECTION CAUSED BY 2019 NOVEL CORONAVIRUS (2019-nCoV) App 20210246448 - TANG; Danny ; et al.	2021-08-12
Peptide Docking Vehicle for Targeted Nucleic Acid Delivery App 20210214726 - LU; Xiaoyong ; et al.	2021-07-15
Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection Grant 11,058,779 - Lu , et al. July 13, 2	2021-07-13
Composition and Methods of Controllable Co-Coupling Polypeptide Nanoparticle Delivery System for Nucleic Acid Therapeutics App 20210162067 - LU; Xiaoyong ; et al.	2021-06-03
Pharmaceutical Compositions And Methods Of Use For Activation Of Human Fibroblast And Myofibroblast Apoptosis App 20200392507 - Xu; John ; et al.	2020-12-17
Gemcitabine Derivatives for Cancer Therapy App 20200108089 - Lu; Patrick Y. ; et al.	2020-04-09
Handheld high frequency ultrasonic nebulizer for whole respiratory tract drug delivery Grant 10,195,368 - Wang , et al. Fe	2019-02-05
sirna/Nanoparticle Formulations for Treatment of Middle-East Respiratory Syndrome Coronaviral Infection App 20190030187 - Lu; Patrick Y. ; et al.	2019-01-31
Pharmaceutical Composition and Applications Thereof App 20180369273 - Lu; Alan Y. ; et al.	2018-12-27
Multi-targeted RNAi therapeutics for scarless wound healing of skin Grant RE46,873 - Lu , et al. May 29, 2	2018-05-29
Compositions and methods for "resistance-proof" SiRNA therapeutics for influenza Grant 9,868,952 - Lu , et al. January 16, 2	2018-01-16
Compositions Comprising Small Interfering RNA Molecules for Prevention and Treatment of Ebola Virus Disease App 20170233742 - Cai; Yibin ; et al.	2017-08-17
Combinations of TGF.beta. and COX-2 inhibitors and methods for their therapeutic application Grant 9,642,873 - Lu , et al. May 9, 2	2017-05-09
SiRNA compositions and methods for treatment of HPV and other infections Grant 9,506,063 - Lu , et al. November 29, 2	2016-11-29
Portable High Frequency Ultrasonic Nebulizer For The Whole Respiratory Tract Drug Delivery App 20160279352 - WANG; Cheng ; et al.	2016-09-29
Compositions and Methods for "Resistance-Proof" SiRNA Therapeutics for Influenza App 20160068843 - Lu; Patrick Y. ; et al.	2016-03-10
Compositions and methods using siRNA molecules and siRNA cocktails for the treatment of breast cancer Grant 9,012,622 - Lu , et al. April 21, 2	2015-04-21
Multi-targeted RNAi therapeutics for scarless wound healing of skin Grant 8,735,567 - Lu , et al. May 27, 2	2014-05-27
siRNA Compositions and Methods for Treatment of HPV and Other Infections App 20130345284 - Lu; Alan Y. ; et al.	2013-12-26
Compositions and methods using siRNA molecules for treatment of gliomas Grant 8,541,568 - Yan , et al. September 24, 2	2013-09-24
Combinations of TGFBeta and COX-2 Inhibitors and Methods for Their Therapeutic Application App 20130225655 - Lu; Patrick Y. ; et al.	2013-08-29
Dual Targeted siRNA Therapeutics for Treatment of Diabetic Retinopathy and Other Ocular Neovascularization Diseases App 20130123330 - Lu; Patrick Y. ; et al.	2013-05-16
Rare Earth-Doped Up-Conversion Nanoparticles for Therapeutic and Diagnostic Applications App 20130115295 - Wang; Qiang ; et al.	2013-05-09
Sirna Compositions Promoting Scar-Free Wound Healing of Skin and Methods for Wound Treatment App 20120115923 - He; Wei-Wu ; et al.	2012-05-10
Compositions and Methods Using siRNA Molecules and siRNA Cocktails for the Treatment of Breast Cancer App 20120071540 - Lu; Patrick Y. ; et al.	2012-03-22
Compositions and Methods Using siRNA Molecules for Treatment of Gliomas App 20110165227 - Yan; Hai ; et al.	2011-07-07
Composition And Methods Of Rnai Therapeutics For Treatment Of Cancer And Other Neovascularization Diseases App 20110124710 - Liu; Yijia ; et al.	2011-05-26
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases Grant 7,893,243 - Liu , et al. February 22, 2	2011-02-22
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases Grant 7,893,244 - Liu , et al. February 22, 2	2011-02-22
Inhibitory Polynucleotide Compositions And Methods For Treating Cancer App 20110038849 - Xie; Frank Y. ; et al.	2011-02-17
Multi-targeted Rnai Therapeutics For Scarless Wound Healing Of Skin App 20100319074 - Lu; Patrick Y. ; et al.	2010-12-16
Composition and method of RNAi therapeutics for treatment of cancer and other neovascularization diseases Grant 7,786,092 - Liu , et al. August 31, 2	2010-08-31
Targets for tumor growth inhibition Grant 7,781,414 - Lu , et al. August 24, 2	2010-08-24
Targets For Tumor Growth Inhibition App 20100203036 - LU; PATRICK Y. ; et al.	2010-08-12
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases Grant 7,723,316 - Liu , et al. May 25, 2	2010-05-25
RNAi Therapeutics for Treatment of Eye Neovascularization Diseases App 20090247604 - Tang; Quinn ; et al.	2009-10-01
COMPOSITION AND METHODS OF RNAi THERAPEUTICS FOR TREATMENT OF CANCER AND OTHER NEOVASCULARIZATION DISEASES App 20090227657 - Liu; Yijia ; et al.	2009-09-10
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases App 20090203894 - Liu; Yijia ; et al.	2009-08-13
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases Grant 7,534,878 - Liu , et al. May 19, 2	2009-05-19
Composition and methods of RNAI therapeutics for treatment of cancer and other neovascularization diseases App 20090118208 - Liu; Yijia ; et al.	2009-05-07
Compositions For Treating Respiratory Viral Infections and Their Use App 20080279920 - Tang; Qingquan ; et al.	2008-11-13
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases App 20080241198 - Liu; Yijia ; et al.	2008-10-02
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases App 20080220027 - Liu; Yijia ; et al.	2008-09-11
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases App 20080153771 - Liu; Yijia ; et al.	2008-06-26
Multi-disciplinary approach to validating or indentifying targets using an in vivo system App 20070237718 - Lu; Patrick Y. ; et al.	2007-10-11
RNAI Agents For Anti-SARS Coronavirus Therapy App 20070203082 - Tang; Quinn T. ; et al.	2007-08-30
Multi-disciplinary approach to validating or identifying targets using an in vivo system App 20040067543 - Lu, Patrick Y. ; et al.	2004-04-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.